Dap-ug, Jellfe E.

HRN: 22-12-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2023
AMPICILLIN 1GM (VIAL)
11/26/2023
11/27/2023
IV
2 G
Now Then Q6
PROM; MSAF Thinly
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: